Next Quarterly Earnings
Thursday, July 30, 2026
CW 31
After-Hours
In 25 days
Vir Biotechnology is a leading US-based biotechnology company dedicated to developing innovative therapies and prevention strategies for serious infectious diseases. The company leverages advanced immunology and technologies, such as monoclonal antibodies, to protect patients globally and improve lives.